Outset Medical (OM) Invested Capital (2019 - 2022)
Outset Medical's (OM) quarterly Invested Capital came in at $1.0 million in Q2 2022, down 86.67% on a QoQ basis from $7.5 million in Q4 2019.
Outset Medical (OM) Invested Capital (2019 - 2022) Analysis & Trends
Outset Medical (OM) has 2 years of Invested Capital data on file, last reported at $1.0 million in Q2 2022.
- On a quarterly basis, Invested Capital changed N/A year-over-year to $1.0 million in Q2 2022; TTM through Mar 2023 was $1.0 million, a N/A change from a year earlier, with the FY2019 full-year figure at $7.5 million, changed N/A from the prior year.
- Invested Capital for Q2 2022 stood at $1.0 million, down from $7.5 million in the prior quarter.
- Over the last five years, Invested Capital for OM reached as high as $7.5 million in Q4 2019 and fell as low as $1.0 million in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 4.41 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 499.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 1.79 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 41.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 7.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 15.00 Mn |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 1.41 Bn |
| 10 | Outset Medical | 80,106.28 | -286.56 Mn | 12.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 1.00 Mn |
| Dec 31, 2019 | 7.50 Mn |